Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Campi, Riccardo; Brookman-May, Sabine; Subiela Henriquez, Jose; AKDOĞAN, BÜLENT; Brausi, Maurizio; Klatte, Tobias; Langenhuijsen, Johan; Linares-Espinos, Estefania; Marszalek, Martin; Roupret, Morgan; Stief, Christian; Volpe, Alessandro; Minervini, Andrea; Rodriguez-Faba, Oscar

doi:10.1016/j.euf.2018.04.001

Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Campi R., Brookman-May S. D., Subiela Henriquez J. D., AKDOĞAN B., Brausi M., Klatte T., ...More

EUROPEAN UROLOGY FOCUS, vol.5, no.6, pp.1029-1057, 2019 (SCI-Expanded, Scopus)

Publication Type: Article / Review
Volume: 5 Issue: 6
Publication Date: 2019
Doi Number: 10.1016/j.euf.2018.04.001
Journal Name: EUROPEAN UROLOGY FOCUS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1029-1057
Hacettepe University Affiliated: Yes

Abstract

Context: To date, established risk factors for prostate cancer (PCa) are limited to age, race, family history, and certain genetic polymorphisms. Despite great research efforts, available evidence on potentially modifiable risk factors is conflicting. Moreover, most studies on PCa risk factors did not consider the impact of prostate-specific antigen (PSA) testing on PCa diagnosis.